Published in Avian Dis on March 01, 2007
Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol (2008) 1.62
Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature (2016) 1.56
Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. J Virol (2010) 1.46
Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells. J Virol (2012) 1.14
Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase. J Gen Virol (2011) 1.03
Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays. J Virol (2008) 1.03
The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage. J Virol (2013) 0.99
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res (2015) 0.92
Investigation of influenza virus polymerase activity in pig cells. J Virol (2012) 0.88
The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activity. PLoS One (2010) 0.80
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis (2009) 4.06
Host species barriers to influenza virus infections. Science (2006) 3.94
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis (2009) 3.76
RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell (2010) 3.59
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis (2009) 3.37
Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 3.03
Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis (2004) 2.94
Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One (2010) 2.04
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol (2010) 1.83
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine (2009) 1.80
A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology (2002) 1.78
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Development of the antibody response in acute HIV-1 infection. AIDS (2004) 1.54
Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Anas platyrhynchos) infected experimentally. Avian Pathol (2008) 1.48
Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0. J Virol (2005) 1.47
HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS (2009) 1.34
Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis (2011) 1.31
Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol (2012) 1.29
Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol (2002) 1.24
Highly pathogenic avian influenza viruses with low virulence for chickens in in vivo tests. Avian Pathol (2007) 1.22
Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses. Influenza Other Respir Viruses (2009) 1.18
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother (2005) 1.16
Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains. J Virol (2002) 1.15
Within-host variation of avian influenza viruses. Philos Trans R Soc Lond B Biol Sci (2009) 1.11
A review of RT-PCR technologies used in veterinary virology and disease control: sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health. Vet Microbiol (2009) 1.10
Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J Clin Virol (2010) 1.06
Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem Biophys Res Commun (2004) 1.06
Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness. J Antimicrob Chemother (2010) 1.03
Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010. Emerg Infect Dis (2011) 1.03
The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3. J Gen Virol (2007) 1.02
The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage. J Virol (2013) 0.99
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. BMC Infect Dis (2011) 0.99
Genetic Characterization of Highly Pathogenic Avian Influenza (H5N8) Virus from Domestic Ducks, England, November 2014. Emerg Infect Dis (2015) 0.97
Low frequency of the Mx allele for viral resistance predates recent intensive selection in domestic chickens. Immunogenetics (2007) 0.94
The effect of age on the pathogenesis of a highly pathogenic avian influenza (HPAI) H5N1 virus in Pekin ducks (Anas platyrhynchos) infected experimentally. Influenza Other Respir Viruses (2010) 0.94
Experimental infection of turkeys with pandemic (H1N1) 2009 influenza virus (A/H1N1/09v). J Virol (2009) 0.90
Expression of the NS3 protease of cytopathogenic bovine viral diarrhea virus results in the induction of apoptosis but does not block activation of the beta interferon promoter. J Gen Virol (2009) 0.88
Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology (2004) 0.88
Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy. Virol J (2010) 0.87
Rapid PCR-based molecular pathotyping of H5 and H7 avian influenza viruses. J Clin Microbiol (2011) 0.85
Analysis of the role of the membrane-spanning and cytoplasmic tail domains of herpes simplex virus type 1 glycoprotein D in membrane fusion. J Gen Virol (2003) 0.85
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. J Clin Virol (2013) 0.84
Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic. Antiviral Res (2011) 0.84
An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA-X protein. Virol J (2014) 0.83
Characterisation of a highly pathogenic influenza A virus of subtype H5N2 isolated from ostriches in South Africa in 2004. Influenza Other Respir Viruses (2009) 0.83
Challenges for accurate and prompt molecular diagnosis of clades of highly pathogenic avian influenza H5N1 viruses emerging in Vietnam. Avian Pathol (2012) 0.82
Influenza pandemics. Adv Exp Med Biol (2011) 0.82
Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons. Antiviral Res (2010) 0.82
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir. ChemMedChem (2009) 0.82
An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo. J Gen Virol (2012) 0.81
Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity. Epidemics (2012) 0.81
Overview of incursions of Asian H5N1 subtype highly pathogenic avian influenza virus into Great Britain, 2005-2008. Avian Dis (2010) 0.79
Evaluation of lateral flow devices for identification of infected poultry by testing swab and feather specimens during H5N1 highly pathogenic avian influenza outbreaks in Vietnam. Influenza Other Respir Viruses (2011) 0.78
Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology. Antiviral Res (2009) 0.76
Unravelling the mysteries of influenza. Lancet (2002) 0.75
Evaluation of two commercial lateral flow devices (LFDs) used for flockside testing of H5N1 highly-pathogenic avian influenza infections in backyard gallinaceous poultry in Egypt. J Mol Genet Med (2010) 0.75
Analytical and semipreparative separation of 25 (R/S)-spirostanol saponin diastereomers using supercritical fluid chromatography. J Sep Sci (2013) 0.75
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. JCI Insight (2017) 0.75